These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 23245802)

  • 21. A novel series of thiazolyl-pyrazoline derivatives: synthesis and evaluation of antifungal activity, cytotoxicity and genotoxicity.
    Altıntop MD; Özdemir A; Turan-Zitouni G; Ilgın S; Atlı Ö; Demirel R; Kaplancıklı ZA
    Eur J Med Chem; 2015 Mar; 92():342-52. PubMed ID: 25576739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of 4-[3-chloro-4-(3-fluorobenzyloxy)anilino]-6-(3-substituted-phenoxy)pyrimidines as dual EGFR/ErbB-2 kinase inhibitors.
    Li S; Guo C; Zhao H; Tang Y; Lan M
    Bioorg Med Chem; 2012 Jan; 20(2):877-85. PubMed ID: 22182581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of novel thiazolone-based compounds containing pyrazoline moiety and evaluation of their anticancer activity.
    Havrylyuk D; Zimenkovsky B; Vasylenko O; Zaprutko L; Gzella A; Lesyk R
    Eur J Med Chem; 2009 Apr; 44(4):1396-404. PubMed ID: 19000643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis and biological evaluation of N-phenylsulfonylnicotinamide derivatives as novel antitumor inhibitors.
    Zhang H; Lu X; Zhang LR; Liu JJ; Yang XH; Wang XM; Zhu HL
    Bioorg Med Chem; 2012 Feb; 20(4):1411-6. PubMed ID: 22277588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, molecular modeling and biological evaluation of 2-(benzylthio)-5-aryloxadiazole derivatives as anti-tumor agents.
    Liu K; Lu X; Zhang HJ; Sun J; Zhu HL
    Eur J Med Chem; 2012 Jan; 47(1):473-8. PubMed ID: 22119130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and molecular docking study of novel coumarin derivatives containing 4,5-dihydropyrazole moiety as potential antitumor agents.
    Liu XH; Liu HF; Chen J; Yang Y; Song BA; Bai LS; Liu JX; Zhu HL; Qi XB
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5705-8. PubMed ID: 20800480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis and biological evaluation of pyrazolyl-nitroimidazole derivatives as potential EGFR/HER-2 kinase inhibitors.
    Tao XX; Duan YT; Chen LW; Tang DJ; Yang MR; Wang PF; Xu C; Zhu HL
    Bioorg Med Chem Lett; 2016 Jan; 26(2):677-683. PubMed ID: 26652482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modification, biological evaluation and 3D QSAR studies of novel 2-(1,3-diaryl- 4,5-dihydro-1H-pyrazol-5-yl)phenol derivatives as inhibitors of B-Raf kinase.
    Yang YS; Zhang F; Tang DJ; Yang YH; Zhu HL
    PLoS One; 2014; 9(5):e95702. PubMed ID: 24827980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure based design and syntheses of amino-1H-pyrazole amide derivatives as selective Raf kinase inhibitors in melanoma cells.
    Kim MH; Kim M; Yu H; Kim H; Yoo KH; Sim T; Hah JM
    Bioorg Med Chem; 2011 Mar; 19(6):1915-23. PubMed ID: 21353571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, biological evaluation and 3D QSAR studies of novel dioxin-containing pyrazoline derivatives with thiourea skeleton as selective HER-2 inhibitors.
    Yang B; Yang YS; Yang N; Li G; Zhu HL
    Sci Rep; 2016 Jun; 6():27571. PubMed ID: 27273260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and synthesis of N-phenylacetyl (sulfonyl) 4,5-dihydropyrazole derivatives as potential antitumor agents.
    Liu XH; Ruan BF; Liu JX; Song BA; Jing LH; Li J; Yang Y; Zhu HL; Qi XB
    Bioorg Med Chem Lett; 2011 May; 21(10):2916-20. PubMed ID: 21486698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New diarylureas and diarylamides containing 1,3,4-triarylpyrazole scaffold: Synthesis, antiproliferative evaluation against melanoma cell lines, ERK kinase inhibition, and molecular docking studies.
    Choi WK; El-Gamal MI; Choi HS; Baek D; Oh CH
    Eur J Med Chem; 2011 Dec; 46(12):5754-62. PubMed ID: 22014559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, biological evaluation, and molecular docking studies of novel 1,3,4-oxadiazole derivatives possessing benzotriazole moiety as FAK inhibitors with anticancer activity.
    Zhang S; Luo Y; He LQ; Liu ZJ; Jiang AQ; Yang YH; Zhu HL
    Bioorg Med Chem; 2013 Jul; 21(13):3723-9. PubMed ID: 23673215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metronidazole acid acyl sulfonamide: a novel class of anticancer agents and potential EGFR tyrosine kinase inhibitors.
    Luo Y; Li Y; Qiu KM; Lu X; Fu J; Zhu HL
    Bioorg Med Chem; 2011 Oct; 19(20):6069-76. PubMed ID: 21920766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of 1-substituted 3-aryl-5-aryl(hetaryl)-2-pyrazolines and study of their antitumor activity.
    Insuasty B; Chamizo L; Muñoz J; Tigreros A; Quiroga J; Abonía R; Nogueras M; Cobo J
    Arch Pharm (Weinheim); 2012 Apr; 345(4):275-86. PubMed ID: 22105771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and structure-activity relationships of N-benzyl-N-(X-2-hydroxybenzyl)-N'-phenylureas and thioureas as antitumor agents.
    Li HQ; Yan T; Yang Y; Shi L; Zhou CF; Zhu HL
    Bioorg Med Chem; 2010 Jan; 18(1):305-13. PubMed ID: 19914837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of imine-pyrazolopyrimidinones and their mechanistic interventions on anticancer activity.
    Baviskar AT; Banerjee UC; Gupta M; Singh R; Kumar S; Gupta MK; Kumar S; Raut SK; Khullar M; Singh S; Kumar R
    Bioorg Med Chem; 2013 Sep; 21(18):5782-93. PubMed ID: 23920485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, anticancer activity and docking studies of novel 4-morpholino-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine derivatives as mTOR inhibitors.
    Zhu W; Sun C; Xu S; Wu C; Wu J; Xu M; Zhao H; Chen L; Zeng W; Zheng P
    Bioorg Med Chem; 2014 Dec; 22(24):6746-54. PubMed ID: 25468038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and quantum chemical studies of new 4-aminoquinazoline derivatives as Aurora A/B kinase inhibitors.
    Zheng M; Zheng Y; Xue Y; Liu Y; An L; Zhang L; Ji M; Xue B; Wu X; Gong X; Gu N; Zhan X
    Chem Biol Drug Des; 2013 Mar; 81(3):399-407. PubMed ID: 23279802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benzochalcones bearing pyrazoline moieties show anti-colorectal cancer activities and selective inhibitory effects on aurora kinases.
    Shin SY; Yoon H; Hwang D; Ahn S; Kim DW; Koh D; Lee YH; Lim Y
    Bioorg Med Chem; 2013 Nov; 21(22):7018-24. PubMed ID: 24095020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.